Circe Bioscience

Founded in 2021 and based in Massachusetts, US, Circe Bioscience Inc. is a bioproduction technology company that provides gas fermentation processes to transform carbon dioxide, water, and waste into organic products to reduce carbon footprint in production. Shannon Nangle (CEO) and Ciaran Dunn are the co-founders of the company. In September 2024, Circe Biosciences Inc. Circe is a manufacturing technology company leveraging gas fermentation to create sustainable, carbon-negative molecules for industrial applications. By converting CO2 emissions into high-value products, Circe provides a scalable solution to enhance supply chain stability while addressing environmental challenges. The firm's proprietary aerobic gas fermentation process transforms point-source CO2 emissions into industry-agnostic molecules. This approach enables manufacturers to access on-spec, drop-in equivalents of essential ingredients used in food production, chemical manufacturing, and sustainable fuel development. Circe's technology removes three kilograms of CO2 for every kilogram of product produced, offering a cost-competitive and environmentally sustainable alternative to traditional raw materials.

1. Seed

   Sep 12, 2024

   Amount

   $5M

   Investors

   Locked